SARS-CoV (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "SARS-CoV" in French language version.

refsWebsite

Global rank French rank

19nih.gov

4^th place

12^th place

3doi.org

2^nd place

3^rd place

1ictvonline.org

5,233^rd place

5,695^th place

1nature.com

234^th place

147^th place

1who.int

195^th place

221^st place

1mdpi.com

2,912^th place

1,010^th place

doi.org

dx.doi.org

(en) Maciej F. Boni, Philippe Lemey, Xiaowei Jiang, Tommy Tsan-Yuk Lam, Blair W. Perry, Todd A. Castoe, Andrew Rambaut et David L. Robertson, « Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic », Nature Microbiology, vol. 5, n^o 11,‎ novembre 2020, p. 1408-1417 (PMID 32724171, DOI 10.1038/s41564-020-0771-4, lire en ligne)
DOI 10.1371/journal.ppat.1010828
(en) Ruth McBride et Burtram C. Fielding, « The Role of Severe Acute Respiratory Syndrome (SARS)-Coronavirus Accessory Proteins in Virus Pathogenesis », Viruses, vol. 4, n^o 11,‎ novembre 2012, p. 2902–2923 (PMID 23202509, PMCID 3509677, DOI 10.3390/v4112902, lire en ligne)

ictvonline.org

talk.ictvonline.org

(en) « Virus Taxonomy: 2018b Release », ICTV, juillet 2018 (consulté le 14 septembre 2019).

mdpi.com

(en) Ruth McBride et Burtram C. Fielding, « The Role of Severe Acute Respiratory Syndrome (SARS)-Coronavirus Accessory Proteins in Virus Pathogenesis », Viruses, vol. 4, n^o 11,‎ novembre 2012, p. 2902–2923 (PMID 23202509, PMCID 3509677, DOI 10.3390/v4112902, lire en ligne)

nature.com

(en) Maciej F. Boni, Philippe Lemey, Xiaowei Jiang, Tommy Tsan-Yuk Lam, Blair W. Perry, Todd A. Castoe, Andrew Rambaut et David L. Robertson, « Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic », Nature Microbiology, vol. 5, n^o 11,‎ novembre 2020, p. 1408-1417 (PMID 32724171, DOI 10.1038/s41564-020-0771-4, lire en ligne)

nih.gov

ncbi.nlm.nih.gov

(en) Maciej F. Boni, Philippe Lemey, Xiaowei Jiang, Tommy Tsan-Yuk Lam, Blair W. Perry, Todd A. Castoe, Andrew Rambaut et David L. Robertson, « Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic », Nature Microbiology, vol. 5, n^o 11,‎ novembre 2020, p. 1408-1417 (PMID 32724171, DOI 10.1038/s41564-020-0771-4, lire en ligne)
https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=228330
(en) Ruth McBride et Burtram C. Fielding, « The Role of Severe Acute Respiratory Syndrome (SARS)-Coronavirus Accessory Proteins in Virus Pathogenesis », Viruses, vol. 4, n^o 11,‎ novembre 2012, p. 2902–2923 (PMID 23202509, PMCID 3509677, DOI 10.3390/v4112902, lire en ligne)
Thiel, Volker, et al Mechanisms and enzymes involved in SARS coronavirus genome expression J Gen Virol 2003 84: 2305-2315
Kumar Singh Saikatendu, Jeremiah S. Joseph et al, Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein , Journal of Virology, April 2007, p. 3913-3921, Vol. 81, No. 8
URJIT, M., B. LIU, S. JAMEEL, et al. 2004. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem. J. 383: 1–6.
FANG, X., L. YE, K.A. TIMANI, et al. 2005. Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus. J. Biochem. Mol. Biol. 38: 381–385.
Du L, et al. The spike protein of SARS-CoV — a target for vaccine and therapeutic development, Nat Rev Microbiol. 2009 March ; 7(3): 226–236. doi:10.1038/nrmicro2090.
Li W, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature 2003;426:450–454. [PubMed: 14647384]
NAMITA S AND SUNIL K. LAL, The Molecular Biology of SARS Coronavirus, Ann. N.Y. Acad. Sci. 1102: 26–38 (2007). C 2007 New York Academy of Sciences. doi: 10.1196/annals.1408.002
Matthew F and Ralph B, Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation, MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, Dec. 2008, p. 672–685 Vol. 72, No. 41092-2172/08/$08.000 doi:10.1128/MMBR.00015-08
Wong SS, Yuen KY. The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother 62: 437–441, 2008.
Chien-Te K. Tseng, et al, Apical Entry and Release of Severe Acute Respiratory Syndrome-Associated Coronavirus in Polarized Calu-3 Lung Epithelial Cells J Virol. 2005 August; 79(15): 9470–9479. doi: 10.1128/JVI.79.15.9470-9479.2005
Jiang Gu and Christine Korteweg, Pathology and Pathogenesis of Severe Acute Respiratory Syndrome, The American Journal of Pathology, Vol. 170, No. 4, April 2007.
Gu, J., et al 2005. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202: 415–424.
cBuchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A. 2004;101:9804-9
Pravin K. Bhatnagar, et al Molecular Targets for Diagnostics and Therapeutics of Severe Acute Respiratory Syndrome (SARS-CoV) 2009, J Pharm Pharm Sci. ; 11(2): 1s–13s.
Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. doi:10.1371/journal.pmed.0030343
Zhu, M. 2004. SARS immunity and vaccination. Cell. Mol. Immunol. 1:193-198

who.int

(en) « Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 », OMS, 31 décembre 2003 (consulté le 14 septembre 2019).